Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSpire Healthcare Group Plc

Spire Healthcare Group Plc

Healthcare Medical Care Facilities
PortfolioPortfolio WatchlistWatchlist
Company price
248.5 GBX 0.00(0%)
Last update at 2026-10-27T16:35:00Z
VOLUME
409387
Market Cap
596.46M
P/E
37.06

Momentum Score

…

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. The company operates in three segments: Hospitals Business, Vita Health Group, and The Doctors Clinic Group. It provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. The company also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, it provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. Further, the company offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal surgery and treatments, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, it provides treatments in the areas of back surgery, breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
248.00
Low
249.00
High
52 Week Price Range
140.80
Low
256.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Spire Healthcare Group Plc runs private hospitals, clinics and diagnostic centres in the UK offering elective surgery, outpatient care and diagnostics to insured, self-pay and NHS-funded patients. Long-term growth may be supported by an ageing population, NHS waiting lists that drive outsourced elective demand and expansion of outpatient diagnostics. The company appears positioned to benefit from scale in UK private care.
Key risks include regulatory and reimbursement changes, reliance on NHS and insurer contracts and margin pressure from staffing shortages and cost inflation that could reduce volumes and profitability.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
248.50
Dividend Yield
1.02%
Revenue TTM
1579.80M
Revenue Per Share
3.95
Gross Profit TTM
716.10M
Debt / Equity
1.77
ROE
2.31%
Net Debt
1281.10M
ROCE
7.04%
Diluted EPS TTM
0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 18.60M 38.30M 34.60M 3.90M -1.90M
Minority interest - -0.60M -0.60M 0.40M -0.80M
Net income 16.40M 25.40M 27.30M 8.60M -8.90M
Gross profit 599.10M 683.60M 520.60M 538.40M 491.20M
Reconciled depreciation - 112.20M 103.60M 97.90M 97.10M
Ebit 142.90M 138.20M 127.60M 95.40M 87.00M
Ebitda 262.50M 250.40M 231.20M 187.80M 177.20M
Depreciation and amortization 119.60M 112.20M 103.60M 92.40M 90.20M
Operating income 142.90M 137.50M 126.50M 95.40M 87.00M
Other operating expenses 1436.90M 1373.70M 1232.50M 1106.10M 1026.20M
Interest expense 105.00M 98.40M 93.00M 85.90M 87.80M
Tax provision - 12.30M 6.70M -4.30M 7.00M
Interest income - 0.70M 1.40M 0.00M 0.00M
Net interest income - -99.20M -91.60M -91.50M -88.80M
Income tax expense 1.40M 12.30M 6.70M -4.30M 7.00M
Total revenue 1579.80M 1511.20M 1359.00M 1198.50M 1106.20M
Total operating expenses 456.20M 546.10M 394.10M 446.00M 411.20M
Cost of revenue 980.70M 827.60M 838.40M 660.10M 615.00M
Total other income expense net -124.30M -99.20M -91.90M -91.50M -88.90M
Net income from continuing ops - 26.00M 27.90M 8.20M -8.90M
Net income applicable to common shares - - - 8.60M -9.70M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 2377.10M 2343.20M 2288.10M 2159.80M 2237.40M
Intangible assets 25.10M 25.80M 27.20M - -
Other current assets 28.70M 29.70M 27.00M 1.10M 104.00M
Total liab 1633.40M 1597.00M 1550.30M 1434.70M 1532.60M
Total stockholder equity 742.80M 748.40M 739.90M 731.00M 709.60M
Other current liab 141.70M 132.90M 139.20M 120.50M 157.90M
Common stock 4.00M 4.00M 4.00M 4.00M 4.00M
Capital stock - 4.00M 4.00M 4.00M 4.00M
Retained earnings -463.20M -462.90M -472.80M -485.70M -496.10M
Other liab - - - 56.20M 57.70M
Good will 419.70M 411.60M 411.10M 345.80M 334.80M
Other assets - - - 4.60M -
Cash 34.70M 41.20M 49.60M 74.20M 202.60M
Total current liabilities 346.80M 341.70M 317.60M 283.40M 302.10M
Current deferred revenue 8.30M - 10.40M - -
Net debt 1281.10M 1238.70M 1207.40M 1116.60M 1062.70M
Short term debt 110.70M 105.40M 101.80M 95.70M 92.50M
Short long term debt - 3.60M 3.40M 2.90M 5.70M
Short long term debt total 1315.80M 1279.90M 1257.00M 1190.80M 1265.30M
Other stockholder equity 825.80M 829.10M 829.30M 1212.70M 1201.70M
Property plant equipment - - - 1584.40M 1553.50M
Total current assets 217.60M 225.30M 220.60M 220.00M 346.80M
Net tangible assets - - - 385.20M 374.80M
Short term investments - 2.50M 10.00M - -
Net receivables 108.00M 105.30M 99.70M 54.80M 80.80M
Long term debt - 363.50M 361.90M 321.40M 421.80M
Inventory 46.20M 46.60M 44.30M 40.60M 40.20M
Accounts payable 86.10M 84.90M 63.90M 67.20M 51.70M
Accumulated other comprehensive income 376.20M 378.20M 379.40M - -
Non currrent assets other 3.90M 16.70M 10.40M 9.60M 2.30M
Non current assets total 2159.50M 2117.90M 2067.50M 1939.80M 1890.60M
Capital lease obligations - 912.80M 891.70M 866.50M 837.80M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -99.00M -157.20M -95.30M 0.40M
Change to liabilities - - - 8.20M 14.30M
Total cashflows from investing activities -90.40M -99.00M -157.20M -95.30M -48.30M
Net borrowings - 0.00M 40.00M -120.20M -14.70M
Total cash from financing activities -135.40M -145.10M -82.90M -214.70M -39.20M
Change to operating activities - - - -15.90M -2.70M
Net income 16.40M 25.40M 27.30M 3.90M -1.90M
Change in cash -6.50M -8.40M -24.60M -128.40M 96.30M
Begin period cash flow 41.20M 49.60M 74.20M 202.60M 106.30M
End period cash flow 34.70M 41.20M 49.60M 74.20M 202.60M
Total cash from operating activities 219.30M 235.70M 215.50M 181.60M 183.80M
Issuance of capital stock - -8.50M -0.60M 3.10M -
Depreciation 119.60M 112.20M 103.60M 97.90M 97.10M
Other cashflows from investing activities - 10.30M 0.40M - -
Dividends paid 9.20M 8.50M 2.00M 0.30M 0.10M
Change to inventory 0.40M -2.30M -3.70M -0.40M -1.90M
Change to account receivables -5.10M -11.00M -12.70M -6.90M 1.70M
Sale purchase of stock -8.70M -11.60M -3.10M - -
Other cashflows from financing activities -119.70M -98.80M -117.20M 207.50M -48.30M
Change to netincome - - - 90.10M 85.00M
Capital expenditures 76.30M 112.10M 84.40M 87.70M 69.30M
Change in working capital -5.20M -16.00M -15.50M -15.00M 11.40M
Stock based compensation - 4.70M 3.70M 2.30M 2.80M
Other non cash items 88.50M 109.40M 96.40M 92.50M 98.10M
Free cash flow 143.00M 123.60M 115.50M 93.90M 114.50M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SPI
Spire Healthcare Group Plc		 -
-%		 248.50 37.06 13.91 0.38 0.78 1.18 7.70
CVSG
CVS Group Plc		 12.00
0.92%		 1316.00 50.87 12.08 1.18 2.69 1.52 9.51
OHGR
One Health Group Plc		 2.00
0.65%		 310.00 24.09 18.15 1.06 2.75 0.75 10.53
KNB
Kanabo Group PLC		 -0.22
99.02%		 0.00 - - 1.25 0.24 0.07 -2.21

Profile*

Spire Healthcare Group Plc

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. The company operates in three segments: Hospitals Business, Vita Health Group, and The Doctors Clinic Group. It provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. The company also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, it provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. Further, the company offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal surgery and treatments, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, it provides treatments in the areas of back surgery, breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

3 Dorset Rise, London, United Kingdom, EC4Y 8EN

44 20 7427 9000

https://www.spirehealthcare.com

17000

Name Title Year Born
Mr. Justin J. Ash BA (Hons) CEO & Exec. Director NA
Mr. Jitesh Himatlal Sodha CFO & Exec. Director (Leave of Absence) 1968
Harbant Samra Group Financial Controller & CFO NA
Mr. John Forrest Chief Operating Officer NA
Angus Prentice Interim Head of Investor Relations NA
Ms. Shelley Thomas Group Human Resurces Director NA
Mr. Mathew Mason Head of Supply Chain & Purchasing (Central) NA
Mr. Peter Corfield Chief Commercial Officer NA
Philip Davies Company Sec. NA
Mr. Justinian Joseph Ash BA (Hons) CEO & Executive Director 1965

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…